Add like
Add dislike
Add to saved papers

Selenization of Cu 2 ZnSnS 4 Enhanced the Performance of Dye-Sensitized Solar Cells: Improved Zinc-Site Catalytic Activity for I 3 .

Cu2 ZnSnS4 (CZTS) and Cu2 ZnSn(S,Se)4 (CZTSSe) as promising photovoltaic materials have drawn much attention because they are environmentally benign and earth-abundant elements. In this work, the monodispersed, low-cost Cu2 ZnSnS4 nanocrystals with small size have been controllably synthesized via a wet chemical routine. And CZTSSe could be easily prepared after selenization of CZTS. When they are employed as counter electrodes (CEs) for dye-sensitized solar cells (DSSCs), the power conversion efficiency (PCE) has been improved from 3.54% to 7.13% as CZTS is converted to CZTSSe, which is also compared to that of Pt (7.62%). The exact reason for the enhanced catalytic activity of I3 - is discussed with the work function and density functional theory (DFT) when CZTSSe converted from CZTS. The results of a Kelvin probe suggest that the work function of CZTSSe (5.61 eV) is closer to that of Pt (5.65 eV) and higher than that of CZTS, which matched the redox shuttle potential better. According to the theory calculation, all the atomic and bond populations changed significantly when Se replaced partly the S on the CZTS system, especially in the Zn site. During the catalytic process as CEs, the adsorption energy obviously increased compared to those at other sites when I3 - adsorbed on the Zn site in CZTSSe. So, Zn plays an important role for the reduction of I3 - after CZTS is converted to CZTSSe. Based on above analysis, the reason for enhanced performance of DSSCs when CZTS converted to CZTSSe is mainly due to the enhancement of Zn-site activity. This work is beneficial for understanding the catalytic reaction mechanism of CZTS(Se) as CEs of DSSCs.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app